N&O Index Card Listings

Displaying 11-12 of 12 results.
Burroughs Wellcome Company
  • Burroughs Wellcome licenses clot dissolver - Ja 4 90 5C
  • Wellcome announces successors - Ja 17 90 5C
  • Burroughs Wellcome plans $16 million for renovation - Ap 19 90 6C
  • Herpes drug OK'd for shingles - Ap 28 90 3B
  • Burroughs Wellcome to expand its Greenville plant - My 22 90 1B
  • Burroughs Wellcome says panel backs drug (Exosurf) - Jy 25 90 6C
  • Drug to ease babies' breathing approved (Exosurf) - Au 7 90 1B
  • Burroughs' new drug (Exosurf) no breeze - Au 12 90 1F
  • The urban image: Burroughs' benchmark of brilliance - Oc 14 90 3H
  • Burroughs Wellcome study indicates drug effective in treating herpes sores - Oc 25 90 6C
  • Wellcome's annual profits rose; Anti-viral treatment, AZT top drug sales - No 16 90 7C
  • Burroughs Wellcome surpasses $1 billion in sales for first time - No 17 90 7C
  • 4 firms grow as economy contracts; But high-tech projects bring only a few jobs - No 28 90 6C
Burroughs Wellcome Company
  • Burroughs Wellcome, NIH collide over AIDS treatment - Ja 5 91 8C
  • Letter says Burroughs owes credit for drug - Ja 9 91 6C
  • Burroughs Wellcome executive (Reckert) leaves - Fe 12 91 2D
  • Drug shown to prevent herpes up to 3 years - Fe 13 91 10A
  • Maker recalls Sudafed; 2 poison deaths linked to capsules - Mr 4 91 1
  • Firm offers reward in Sudafed tampering case - Mr 8 91 6C
  • Burroughs begins ads on its recall of Sudafed - Mr 14 91 7C
  • Nader-backed group sues Burroughs; Complaint challenges AZT patent - Mr 20 91 6C
  • Burroughs battling to keep rights to AZT patent - Ap 23 91 1D
  • Sudafed maker turns to tablets; 12-hour capsule won't be back - Ap 27 91 1
  • Burroughs Wellcome reports flat sales - My 3 91 6C
  • Burroughs sues to block generic AZT - My 16 91 7C
  • Report says FDA may help fight Burroughs Wellcome's lock on AZT - My 18 91 1
  • (National Cancer) Institute might sue Burroughs (over AZT) - My 21 91 1D
  • NIH won't go to court over AZT patent rights - My 29 91 6C
  • Drug maker to ban smoking; Burroughs Wellcome plans gradual cutoff - Jn 26 91 7C
  • Judge allows Burroughs to sell leftover Sudafed outside U.S. - Jn 29 91 6C
  • Burroughs names marketing officer (Rothwell); Bristol-Myers transfer gets post - Jy 10 91 5C
  • Barr Labs promised license for AZT; But issuance is tied to winning patent suit - Jy 18 91 7C
  • Drug firm attacks wastes; Burroughs to spend $18 million at (Greenville) plant - Au 15 91 6C
  • Burroughs weighs its prescription for giving - Se 8 91 1F
  • Mice created to test drugs for HIV treatment - Se 9 91 1B
  • Burroughs beefs up aid to AIDS patients; But $10 million plan draws fire - Se 11 91 9C
  • AIDS research finds 2 drugs better than 1 - Se 27 91 5B
  • Burroughs Wellcome gives museum $250,000 - Oc 10 91 2B
  • Mich. hospital bars Burroughs salesmen; N.C. drug maker among 6 targeted - Oc 10 91 10C
  • Burroughs Wellcome plans announcement on new drug - No 12 91 1D
  • AIDS activists now cooperating with drug maker - No 13 91 12A
  • FDA gives Burroughs Wellcome go-ahead on new AIDS therapy - No 13 91 1
  • Zovirax recommended to treat chicken pox - No 13 91 9C
  • Burroughs pledges $1.45 million to UNC-CH - De 13 91 6C